IFP Advisors’s Neuronetics STIM Stock Holding History

IFP Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16	Sell	7 -5	-42%	-$12	﹤0.01%	5152
2026 Q2	$16	Buy	12 +9	+300%	+$13	﹤0.01%	5081
2026 Q1	$4	Buy	+3	New	+$5	﹤0.01%	4998

Other funds holding STIM

VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Canton Hathaway Providence, Rhode Island $513M AUM 16.15% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

IFP Advisors's STIM Position: Q3 2026 in Review

IFP Advisors reduced its Neuronetics (STIM) stake by 42% in Q3 2026, selling an estimated $12 and leaving 7 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #5152.

IFP Advisors first reported a position in STIM in Q1 2026 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

IFP Advisors held 7 shares of Neuronetics worth $16 as of Q3 2026.
IFP Advisors sold 5 Neuronetics shares in Q3 2026, an estimated $12.
Neuronetics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5152 holding.
IFP Advisors first reported a position in Neuronetics in Q1 2026 and has held it in 3 quarters since.
10 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.